Navigation Links
Risk of dementia reduced hypertension drugs

According to a new study it is observed that reducing blood pressure by medication can reduce the risk of dementia by half. It is already known that hypertension (high blood pressure) increases the risk of vascular dementia// and Alzheimer's disease. In a study carried out by doctors in Dallas, the effect of lowering blood pressure on dementia rates has been examined.

A group of patients with systolic hypertension - with levels from 160 to 190 mm Hg - were looked at. For around four years, these patients took blood-pressure lowering drugs or placebo. Those on the medication had a 50 per cent lower risk of dementia. The study was then stopped in 1998, when it was realized that lowering blood pressure by medication had the effect of reducing stroke risk; it was considered unethical to keep people on placebo.

People are often told that they should keep on with blood pressure medication to cut their risk of having a heart attack. This new study emphasizes another potential benefit - keeping dementia at stand.


'"/>




Page: 1

Related medicine news :

1. Music aids in curing dementia
2. Hobbies prevent dementia
3. Moderate alcohol consumption protects against dementia
4. Alcohol decreases risk of dementia
5. Consuming fish prevents dementia risk
6. Drinking wine beneficial in dementia
7. Essential tremor can lead to dementia
8. Midlife obesity linked to risk of dementia
9. Obesity in the Middle age can increase risk of developing dementia
10. MRI for distinguishing between dementia and Alzheimer’s diseas
11. A word of caution issued by the FDA for those using antipsychotic drugs for dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology: